Stocks SDGR Financial statements
Financial statementsSchrodinger, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Schrodinger, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 85.5 | 108 | 138 | 181 | 217 | 208 | 256 |
| Cost of revenue | 36.5 | 44.6 | 72.3 | 79.9 | 76 | 75.5 | 113 |
| Gross profit | 49.1 | 63.5 | 65.6 | 101 | 141 | 132 | 143 |
| Research and development | 39.4 | 64.7 | 90.9 | 126 | 182 | 202 | 173 |
| Selling and marketing | 21.4 | 17.8 | 22.2 | 30.6 | 37.2 | 39.9 | 41 |
| General and administrative | 27 | 41.9 | 64 | 90.8 | 99.1 | 99.7 | 95.4 |
| Operating expenses | 87.8 | 124 | 177 | 248 | 318 | 341 | 310 |
| Operating income | -38.7 | -60.9 | -111 | -147 | -177 | -209 | -167 |
| Interest income | 1.88 | 2.25 | 1.06 | 3.95 | |||
| Other non-operating income | 12.7 | 34.6 | 10.6 | -2.31 | 220 | 23.6 | 64.6 |
| Pre-tax income | -26 | -26.3 | -101 | -149 | 42.9 | -186 | -102 |
| Income tax | -0.29 | 0.35 | 0.41 | 0.06 | 2.2 | 1.41 | 0.94 |
| Net income to minority interests | -1.11 | -2.17 | -0.83 | -0 | 0 | ||
| Net income | -24.6 | -24.5 | -100 | -149 | 40.7 | -187 | -103 |
| EBITDA | -35.1 | -57.3 | -109 | -142 | -172 | -203 | -161 |
| EPS, basic | -4.09 | -0.41 | -1.42 | -2.10 | 0.57 | -2.57 | -1.41 |
| EPS, diluted | -4.09 | -0.41 | -1.42 | -2.10 | 0.54 | -2.57 | -1.41 |
| Shares, basic (weighted) | 6 | 60 | 70.6 | 71.2 | 71.8 | 72.7 | 73.4 |
| Shares, diluted (weighted) | 6 | 60 | 70.6 | 71.2 | 75 | 72.7 | 73.4 |
Balance sheet
| FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 26 | 202 | 120 | 90.5 | 155 | 147 | 231 |
| Short-term investments | 59.8 | 440 | 456 | 361 | 308 | 205 | 165 |
| Receivables | 18.7 | 31.4 | 31.7 | 56 | 66 | 236 | 83 |
| Other current assets | 6.47 | 4.41 | 5.03 | 8.57 | 9.93 | 12.2 | 12.5 |
| Total current assets | 119 | 683 | 625 | 534 | 568 | 635 | 519 |
| Property, plant and equipment | 6.27 | 5.14 | 10 | 14.2 | 23.3 | 24.2 | 19.5 |
| Lease right-of-use assets | 12.8 | 10.1 | 75.4 | 106 | 118 | 112 | 103 |
| Goodwill | 0 | 4.79 | 4.79 | 4.79 | 4.79 | ||
| Intangible assets | 0 | 0.59 | 0 | ||||
| Other non-current assets | 2.34 | 2.35 | 2.85 | 3.31 | 6.01 | 4.16 | 6.27 |
| Total assets | 155 | 746 | 756 | 689 | 803 | 823 | 726 |
| Accounts payable | 3.52 | 8.4 | 8.08 | 9.47 | 16.8 | 10.7 | 11.5 |
| Deferred revenue | 25.1 | 45.4 | 55.4 | 57.9 | 56.2 | 112 | 113 |
| Total current liabilities | 45 | 73.2 | 91.2 | 109 | 134 | 192 | 189 |
| Lease liabilities | 8.89 | 7.22 | 77.8 | 105 | 111 | 101 | 92.8 |
| Other non-current liabilities | 0.9 | 0.65 | 0.3 | 0.8 | 0.67 | 0.15 | 1.28 |
| Total liabilities | 57 | 122 | 199 | 241 | 254 | 402 | 362 |
| Paid-in capital | 11.7 | 753 | 787 | 829 | 886 | 946 | 992 |
| Retained earnings | -105 | -130 | -230 | -379 | -338 | -526 | -629 |
| Other comprehensive income | 0.02 | 0.32 | -0.65 | -2.38 | 0.28 | 0.22 | 0.11 |
| Shareholders' equity | -93.4 | 624 | 557 | 448 | 549 | 421 | 364 |
| Minority interests | 0.04 | 0 | 0.01 | 0.01 | 0 | ||
| Total equity | -93.3 | 624 | 557 | 448 | 549 | 421 | 364 |
| Total liabilities and equity | 155 | 746 | 756 | 689 | 803 | 823 | 726 |
| Shares outstanding | 6.12 | 60.7 | 61.8 | 62.2 | 63 |
Cash flow statement
| FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | -25.7 | -26.6 | -101 | -149 | 40.7 | -187 | -103 |
| Depreciation and amortization | 3.64 | 3.66 | 2.85 | 4.34 | 5.55 | 6.16 | 6.02 |
| Stock-based compensation | 2.19 | 10.5 | 26.5 | 39.6 | 47.8 | 49.9 | 43 |
| Deferred income tax | 0 | 0 | 0 | 0 | -0.25 | -0.61 | |
| Change in receivables | -5.04 | -12.7 | -0.32 | -23.7 | -10 | -170 | 153 |
| Change in payables | -0.29 | 4.88 | -0.41 | 1.18 | 7.32 | -6.12 | 0.91 |
| Cash from operations | -26.1 | 16.8 | -70.7 | -120 | -137 | -157 | 13.9 |
| Capital expenditures | -1.84 | -2.54 | -7.17 | -8.01 | -13.4 | -7.31 | -1.44 |
| Acquisitions | 0 | 0 | -6.43 | 0 | 0 | ||
| Purchases of investments | -110 | -520 | -415 | -271 | -321 | -251 | -313 |
| Sales and maturities of investments | 57.2 | 139 | 393 | 365 | 384 | 362 | 355 |
| Cash from investing | -53.9 | -382 | -16.8 | 90 | 193 | 149 | 57.9 |
| Stock issued | 0.55 | 4.18 | 7.93 | 0 | 0 | 8.87 | 0 |
| Cash from financing | 28.7 | 541 | 7.95 | 2.11 | 9.05 | 10.1 | 2.93 |
| Net change in cash | -51.2 | 176 | -79.5 | -27.6 | 65.3 | 1.59 | 74.7 |
| Free cash flow | -27.9 | 14.2 | -77.8 | -128 | -150 | -165 | 12.5 |
| Income taxes paid | 0.14 | 0.38 | 0.45 | 0.79 | 2.83 | 1.08 | -0.01 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 56.9% | Gross profit / revenue. |
| Operating margin | -59.2% | Operating income / revenue. |
| EBITDA margin | -57.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -20.0% | Pre-tax income / revenue. |
| Net margin | -21.0% | Net income / revenue. |
| FCF margin | -50.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -49.0% | Cash from operations / revenue. |
| Return on equity (ROE) | -16.5% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -8.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | -294.9% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 65.2% | Research and development expense / revenue. |
| Stock-based pay / revenue | 14.9% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.3% | Capital expenditures / revenue. |
| D&A / revenue | 2.3% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 23.3% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 12.2% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 18.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 8.0% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 12.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 17.6% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -3.7% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -2.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -13.6% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -6.7% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -10.2% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -11.8% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 1.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -0.5% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 1.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 1.1% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 4.1% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.71x | Current assets / current liabilities. |
| Quick ratio | 2.50x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 2.38x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 48.6% | Total liabilities / total assets. |
| Working capital | $296.6M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.7% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $324.2M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.40x | Revenue / average total assets. |
| Fixed asset turnover | 13.3x | Revenue / average property, plant and equipment. |
| Receivables turnover | 12.1x | Revenue / average receivables. |
| Days sales outstanding | 30 days | 365 x average receivables / revenue. |
| Days payables | 34 days | 365 x average accounts payable / cost of revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.72 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $3.42 | Revenue / diluted weighted shares. |
| FCF per share | -$1.72 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$1.67 | Cash from operations / diluted weighted shares. |
| Book value per share | $4.34 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $4.28 | Tangible book value / shares outstanding. |
| Cash per share | $5.46 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $2.16B | Share price x shares outstanding. |
| Enterprise value | $1.74B | Market cap + total debt - cash - short-term investments. |
| P/S | 8.33x | Market cap / revenue. |
| P/B | 6.56x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 6.66x | Market cap / tangible book value, when positive. |
| EV/Sales | 6.73x | Enterprise value / revenue. |
| FCF yield | -6.0% | Free cash flow / market cap. |
| Earnings yield | -2.5% | Net income / market cap (the inverse of P/E). |
What was Schrodinger, Inc.'s revenue in fiscal 2025?
Schrodinger, Inc. reported revenue of $255.9M for fiscal 2025, 23.3% higher than the year before.
Was Schrodinger, Inc. profitable in fiscal 2025?
No. It reported a net loss of $103.3M.
How much free cash flow did Schrodinger, Inc. generate in fiscal 2025?
Cash from operations of $13.9M minus capital expenditures of $1.4M left free cash flow of $12.5M.